SAN

100.72

+1.15%↑

EI

250.8

-5.75%↓

SHL.DE

48.09

-2.89%↓

ARGX

545.4

+3.57%↑

FRE

39.69

+2.21%↑

SAN

100.72

+1.15%↑

EI

250.8

-5.75%↓

SHL.DE

48.09

-2.89%↓

ARGX

545.4

+3.57%↑

FRE

39.69

+2.21%↑

SAN

100.72

+1.15%↑

EI

250.8

-5.75%↓

SHL.DE

48.09

-2.89%↓

ARGX

545.4

+3.57%↑

FRE

39.69

+2.21%↑

SAN

100.72

+1.15%↑

EI

250.8

-5.75%↓

SHL.DE

48.09

-2.89%↓

ARGX

545.4

+3.57%↑

FRE

39.69

+2.21%↑

SAN

100.72

+1.15%↑

EI

250.8

-5.75%↓

SHL.DE

48.09

-2.89%↓

ARGX

545.4

+3.57%↑

FRE

39.69

+2.21%↑

Search

Merck KGaA

Abierto

125.7 1.21

Resumen

Variación precio

24h

Actual

Mínimo

122.65

Máximo

126.6

Métricas clave

By Trading Economics

Ingresos

-142M

667M

Ventas

152M

5.4B

P/B

Media del Sector

26.27

63.778

BPA

2.2

Rentabilidad por dividendo

1.34

Margen de beneficio

12.311

EBITDA

85M

1.6B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+38.91% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.34%

2.39%

Próximas Ganancias

15 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

33B

98B

Apertura anterior

124.49

Cierre anterior

125.7

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Merck KGaA Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

6 mar 2025, 06:27 UTC

Ganancias

Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results

11 feb 2025, 07:03 UTC

Adquisiciones, fusiones, absorciones

Germany's Merck in Talks to Buy SpringWorks Therapeutics

10 feb 2025, 16:38 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

SpringWorks Therapeutics Shares Rise on Report it May be Acquired

6 mar 2025, 11:18 UTC

Charlas de Mercado
Ganancias

Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk

6 mar 2025, 11:14 UTC

Charlas de Mercado

Merck KGaA's Outlook Signals Greater Transparency -- Market Talk

6 mar 2025, 08:20 UTC

Charlas de Mercado
Ganancias

Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 Adj EPS EUR8.63

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 EBIT EUR3.645B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 After-Tax Profit EUR2.79B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 EBITDA EUR5.78B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 Sales EUR21.16B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA Keeps Dividend at EUR2.20

6 mar 2025, 06:00 UTC

Ganancias

Analysts Saw Merck KGaA 2024 Sales at EUR21.14B

6 mar 2025, 06:00 UTC

Ganancias

Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B

11 feb 2025, 16:45 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk

11 feb 2025, 10:54 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk

11 feb 2025, 10:52 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk

6 ene 2025, 13:08 UTC

Adquisiciones, fusiones, absorciones

Merck KGaA: Transaction closed on Dec. 23, 2024

6 ene 2025, 13:07 UTC

Adquisiciones, fusiones, absorciones

Merck KGaA: Didn't Disclose Financial Details

6 ene 2025, 13:06 UTC

Adquisiciones, fusiones, absorciones

Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio

6 ene 2025, 13:04 UTC

Adquisiciones, fusiones, absorciones

Merck KaA Acquires HUB Organoids Holding B.V. to Expand Its Next-Generation Biology Portfolio

17 dic 2024, 13:05 UTC

Adquisiciones, fusiones, absorciones

Merck: Deal Expected to Close By End Dec. 2024

17 dic 2024, 13:04 UTC

Adquisiciones, fusiones, absorciones

Merck: Terms of Deal Undisclosed

17 dic 2024, 13:04 UTC

Adquisiciones, fusiones, absorciones

Merck Signs Pact to Buy HUB Organoids

17 dic 2024, 13:03 UTC

Adquisiciones, fusiones, absorciones

Merck: Acquisition Advances Next Gen Biology Portfolio

17 dic 2024, 13:03 UTC

Adquisiciones, fusiones, absorciones

Merck to Buy HUB Organoids Holding

14 nov 2024, 11:15 UTC

Charlas de Mercado

Merck KGaA's Sales Target Dragged by Muted China Outlook -- Market Talk

Comparación entre iguales

Cambio de precio

Merck KGaA Esperado

Precio Objetivo

By TipRanks

38.91% repunte

Estimación a 12 meses

Media 175.86 EUR  38.91%

Máximo 190 EUR

Mínimo 160 EUR

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Merck KGaA Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

7

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

126.35 / 130.5Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Merck KGaA

There is no Profile data available for MRK.BE.